India Diagnostics Services Market Set to Surge USD 150.89 Billion by 2035

India Diagnostics Services Market Size and Growth Insights

The India diagnostics services market size valued at USD 56.60 billion in 2026 and is projected to surpass USD 150.89 billion by 2035, growing at a CAGR of 11.5% during the forecast period 2026 to 2035.

The widespread adoption of diverse medical tests and examinations by healthcare providers to find, assess, and monitor health issues is termed diagnostic services. However, India’s diagnostic services mainly cover laboratory blood work, imaging scans, and specific physiological testing to recommend adequate treatment strategies. The growing demand for these services is primarily fueled by a rise in different non-communicable diseases, like diabetes, CVD, and cancer, with a surge in screening volumes for tuberculosis via a national program. Alongside this, Indian consumers are increasingly stepping into preventive health awareness that promotes annual health check-ups and clustered diagnostic packages. Moreover, accelerated public health investment, like the Ministry of Health and Family Welfare’s ₹1,06,530.42 crore for 2026–27, is empowering the development of public lab facilities. At the same time, the execution of the PM-ABHIM Scheme offers funding to integrate public health laboratories and strengthen testing reach across districts.

AI Revolution

Nowadays, eminent Indian labs and diagnostic facilities are approaching to embrace AI solutions, such as 5C Network and other local center systems that indicate urgent concerns, such as strokes or lung nodules, by reducing critical CT read times to minutes. Furthermore, leading pioneers have been developing AI-powered smart stethoscopes that record heart sounds and use cloud-based AI to determine abnormalities. This supports community health workers in different areas, such as Maharashtra and Uttar Pradesh. Besides this, certain startups, like Remidio and MedInnovate, have rolled out tools that utilise mobile imaging for faster screening of diabetic retinopathy, glaucoma, tuberculosis, and malaria, cutting diagnostic turnaround times in half. Somehow, India’s research activities have expanded AI algorithms in oncology and pathology that support processing larger imaging and histopathology datasets to help clinicians with cancer care and tailored treatment planning.

Recent Initiatives

• October 2026: The Indian Council of Medical Research (ICMR) chose seven academic and research institutions to receive up to ₹15 crore each over five years to establish indigenous diagnostic and medical device technologies.
• October 2026: Boule Diagnostics AB and Q-Line Biotech Limited collaborated to streamline the commercial structure, sync incentives for long-term growth, and develop a robust foundation. 
• September 2026: Thyrocare Technologies Limited joined with SecondMedic and introduced a new diagnostic laboratory in Jamshedpur, Jharkhand, to empower its aim of quality and reliable diagnostic services. 

India Diagnostic Services Market Segmental Outlook

India Diagnostic Services Market Developing Shifts

• AI-Assisted Solution: Currently, AI algorithms are prioritising urgent scans and lowering critical turnaround times. This includes the government-led launch of health AI that standardises landscapes via the Ayushman Bharat Digital Mission to ensure diagnostic models.
• Advancing Tailored Medicine: Eventual progressions are fostering molecular and genetic testing by unveiling mainstream triage, such as the genomic centre introduced by Metropolis Healthcare, which employs biomarker-driven and high-throughput sequencing data to customize individual oncology and chronic care trajectories.
• Remote-Based Innovations: India’s efficient diagnostic area is seeking the development of home-based testing for urban consumers and point-of-care devices, especially for rural clinics, that allow expedited, precise diagnostic solutions.

Future Outlook 

During 2026-2035, India could face a huge rise in different chronic condition cases, which will ultimately lead to the joining of national chains with regional providers to evolve premium, central processing hubs and localized rapid collection. These instances will transform AI solutions by using them in regular clinical activities. Alongside this, AI will push expansion of top-tier imaging and clinical efficacy to tier-2, 3, and 4 cities, significantly reducing the stress on urban specialists. Day by day, the Indian government is broadly advertising affordable, portable screening and POC devices personalized mainly for primary healthcare systems. With a focus on genetic testing approaches, India’s eminent laboratories are embracing liquid biopsies, reproductive genetics, and DNA or RNA typing into their key test portfolios. On the other hand, the market will bolster AI-powered blood testing for early Alzheimer's detection to substantially reduce historical screening expenses. 

Segments Covered

By Service Type

• Pathology Testing
• Radiology and Imaging
• Molecular and Genomic Diagnostics
• Preventive and Wellness Testing

By Test Type

• Clinical Chemistry
• Hematology
• Immunology and Serology
• Microbiology
• Molecular Diagnostics

By Application

• Infectious Disease Diagnosis
• Diabetes and Metabolic Disorder Monitoring
• Cardiovascular Disease Diagnosis
• Oncology Diagnostics
• Preventive Health Screening

By Service Provider

• Independent Diagnostic Laboratories
• Organized Diagnostic Chains
• Hospital-Based Laboratories
• Specialized Diagnostic Centers

Empower your strategy with expert insights, purchase this premium research@ https://www.cervicornconsulting.com/buy-now/3072

Ask here for more details@ sales@cervicornconsulting.com